Pay in 4 interest-free payments of $6.82 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
Mechanisms proposed include activation of focal adhesion kinasepaxillin pathways, stimulation of growth factor signaling, and support for nitric oxidemediated vascular responses
doi:10.2147/DDDT.S82030
The systemic distribution of TB-500 means that a single injection can influence repair processes across multiple tissue sites simultaneously
BENEFITS Combined mechanism studied for complementary tissue-repair pathways in a single formulation Convenience eliminates the need to source and reconstitute two separate vials Recovery research explored for combined effects on connective tissue and muscle models Anti-inflammatory linked to dual anti-inflammatory pathways from both compounds Wound healing associated with accelerated recovery timelines in preclinical models WHAT RESEARCHERS LOOK AT Synergistic vs additive effects of BPC-157 and TB-500 co-administration Angiogenesis promotion from the dual-peptide combination Comparative recovery timelines: blend vs individual compounds Optimal dosing ratios in combined formulations Fibroblast migration and collagen deposition from dual pathways QUICK SPECS Form: Lyophilized peptide blend Net per vial: 10 mg total (BPC-157 5mg + TB-500 5mg) Purity: 99% (HPLC verified) Identity: MS-verified (per COA) Storage: 28C, protect from light and moisture Reconstitution: Use bacteriostatic water (sold separately) IDENTITY BASICS Components: BPC-157 (CAS 137525-51-0) + TB-500 (CAS 77591-33-4) Blend ratio: 1:1 (5mg each) WHY CHOOSE DURHAM PEPTIDES FOR THE WOLVERINE STACK
Maintenance phase: After loading, protocols typically reduce to 2-2.5mg once weekly or 2mg twice monthly
COA available on request
US$ 29.50
US$ 21.13
US$ 25.09
